Cargando…

Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders

The therapeutic benefits of the current medications for patients with psychiatric disorders contrast with a great variety of adverse effects. The endocannabinoid system (ECS) components have gained high interest as potential new targets for treating psychiatry diseases because of their neuromodulato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro, Daniela, Gasparyan, Ani, Navarrete, Francisco, Torregrosa, Abraham B., Rubio, Gabriel, Marín-Mayor, Marta, Acosta, Gabriela B., Garcia-Gutiérrez, Maria Salud, Manzanares, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104141/ https://www.ncbi.nlm.nih.gov/pubmed/35563156 http://dx.doi.org/10.3390/ijms23094764

Ejemplares similares

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020)

Biomarkers of the Endocannabinoid System in Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2022)

Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach
por: Navarro, Daniela, et al.
Publicado: (2023)

Cognitive Alterations in Addictive Disorders: A Translational Approach
por: Gasparyan, Ani, et al.
Publicado: (2023)

Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
por: García-Gutiérrez, María Salud, et al.
Publicado: (2022)

Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD
por: Gasparyan, Ani, et al.
Publicado: (2021)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

CB2 Receptor Involvement in the Treatment of Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
por: García-Gutiérrez, Maria Salud, et al.
Publicado: (2020)

Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences
por: Navarrete, Francisco, et al.
Publicado: (2020)

Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
por: Austrich-Olivares, Amaya, et al.
Publicado: (2022)

Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain
por: La Porta, Carmen, et al.
Publicado: (2015)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
por: García-Gutiérrez, María S., et al.
Publicado: (2020)

Pairing Binge Drinking and a High-Fat Diet in Adolescence Modulates the Inflammatory Effects of Subsequent Alcohol Consumption in Mice
por: González-Portilla, Macarena, et al.
Publicado: (2021)

Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model
por: García-Gutiérrez, María Salud, et al.
Publicado: (2023)

Neuropsychophysiological Measures of Alcohol Dependence: Can We Use EEG in the Clinical Assessment?
por: Jurado-Barba, Rosa, et al.
Publicado: (2020)

Gestational and early postnatal hypothyroidism alters VGluT1 and VGAT bouton distribution in the neocortex and hippocampus, and behavior in rats
por: Navarro, Daniela, et al.
Publicado: (2015)

Endocannabinoid System and Psychiatry: In Search of a Neurobiological Basis for Detrimental and Potential Therapeutic Effects
por: Marco, Eva M., et al.
Publicado: (2011)

Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats
por: Le Bacquer, Olivier, et al.
Publicado: (2021)

Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses
por: Hill, Matthew N, et al.
Publicado: (2013)

Endocannabinoids and Reproduction
por: Meccariello, Rosaria, et al.
Publicado: (2014)

Editorial: The Search for Biomarkers in Psychiatry
por: Garcia-Gutierrez, Maria S., et al.
Publicado: (2021)

Alterations of Stress-Related Glucocorticoids and Endocannabinoids in Hair of Chronic Cocaine Users
por: Voegel, Clarissa D, et al.
Publicado: (2021)

Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders
por: Estrada, José Antonio, et al.
Publicado: (2020)

Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
por: Vasincu, Alexandru, et al.
Publicado: (2022)

Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder
por: Gesell, Felix K, et al.
Publicado: (2013)

Blood Levels of Endocannabinoids, Oxylipins, and Metabolites Are Altered in Hemodialysis Patients
por: Watkins, Bruce A., et al.
Publicado: (2022)

The endocannabinoid 2-arachidonoylglycerol promotes endoplasmic reticulum stress in placental cells
por: Almada, Marta, et al.
Publicado: (2020)

Role of endocannabinoids in regulating drug dependence
por: Parolaro, Daniela, et al.
Publicado: (2007)

The Endocannabinoid System and Physical Exercise
por: Matei, Daniela, et al.
Publicado: (2023)

Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders
por: Morcuende, Alvaro, et al.
Publicado: (2022)

Noradrenergic depletion causes sex specific alterations in the endocannabinoid system in the Murine prefrontal cortex
por: Urquhart, M.A., et al.
Publicado: (2019)

Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010)

Endocannabinoids and Immunity
por: Chiurchiù, Valerio
Publicado: (2016)

Endocannabinoids in the Gut
por: DiPatrizio, Nicholas V.
Publicado: (2016)

Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex
por: Pava, Matthew J., et al.
Publicado: (2014)

Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis
por: Ferrara, Anne Lise, et al.
Publicado: (2019)

Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder
por: Zou, Mingyang, et al.
Publicado: (2021)

Cannabis alters epigenetic integrity and endocannabinoid signalling in the human follicular niche
por: Fuchs Weizman, Noga, et al.
Publicado: (2021)

Motion Sickness, Stress and the Endocannabinoid System
por: Choukèr, Alexander, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dhllv2op03lr65tfm2lq13jv3p